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ABSTRACT
Objective To describe prevalence, prenatal diagnosis 
and epidemiological data on oesophageal atresia from 
23 well-defi ned European regions and compare the 
prevalence between these regions.
Design Population-based study using data from a 
large European database for surveillance of congenital 
anomalies (EUROCAT) for two decades (1987–2006).
Settings Twenty-three participating registries based 
on multiple sources of information including information 
about live births, fetal deaths with gestational age ≥20 
weeks and terminations of pregnancy.
Patients 1222 cases of oesophageal atresia in a 
population of 5 019 804 births.
Results The overall prevalence was 2.43 cases 
per 10 000 births (95% CI 2.30 to 2.57). There were 
regional differences in prevalence ranging from 1.27 
to 4.55. Prenatal detection rates varied by registry 
from >50% of cases to <10% of cases. A total of 
546 cases (44.7%) had an isolated oesophageal 
anomaly, 386 (31.6%) were multiple malformed 
and 290 (23.7%) had an association or a syndrome. 
There were 1084 live born cases (88.7%), 43 cases 
were fetal deaths and 95 cases were terminations 
of pregnancy. One-week survival for live births was 
86.9% and 99.2% if the gestational age was ≥38 
weeks and isolated oesophageal atresia was present. 
Males accounted for 57.3% of all cases and 38.5% of 
live born cases were born with gestational age <37 
weeks.
Conclusion There were regional differences in preva-
lence of oesophageal atresia in Europe. Half of all cases 
had associated anomalies. Prenatal detection rate 
increased from 26% to 36.5% over the two decades. 
Survival in infants with isolated oesophageal atresia 
born at term is high.
INTRODUCTION
Oesophageal atresia is a congenital anomaly of 
the oesophagus and in most cases involves the 
trachea. The prevalence in reported case series 
varies from 1 in 2500 to 1 in 4500 births.1–5 The 
anomaly arises from a developmental disrup-
tion with faulty separation of the embryogenic 
foregut into trachea and oesophagus during the 
fi fth to sixth week of embryonic life. In 78–90% 
of reported cases there is a tracheo-oesophageal 
fi stula between the lower segment of the oesoph-
agus and trachea (gross type C).5–14 The aetiol-
ogy of oesophageal atresia is unknown. Different 
environmental factors have been suggested to 
play a role in the development of oesophageal 
atresia.15
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What is already known on this topic
 The prognosis after surgery is good in term  ▶
infants with isolated oesophageal atresia.
 Prevalence varies in different populations and  ▶
no changes in prevalence over time have been 
shown.
The proportion of associated anomalies is high. ▶
What this study adds
 Prevalence of oesophageal atresia has been  ▶
stable over the last 20 years. The prevalence 
differs within European regions.
 The study characterises the associated  ▶
anomalies and documents their impact on 
mortality in patients with oesophageal atresia.
 Prenatal detection rates of oesophageal atresia  ▶
are increasing; termination of pregnancy for 
isolated oesophageal atresia is very rare.
Associated anomalies are reported to be present 
in a high proportion of patients with oesophageal 
atresia.1 3–6 13 14 16–22 Associated anomalies can be 
chromosomal (Down’s syndrome, Edward’s syn-
drome (trisomy 18)), part of a genetic syndrome 
(CHARGE syndrome, Feingold syndrome and oth-
ers), an association such as VACTERL-association 
or multiple anomalies without a pattern.
Survival with oesophageal atresia is only pos-
sible with surgical correction. Survival rates after 
surgery are reported to be around 90% includ-
ing patients with severe associated anomalies 
and up to almost 100% in term infants without 
associated anomalies.17 20 23–25 Some studies only 
include cases referred for surgery and not the 
total population of live born cases with oesopha-
geal atresia.
The aim of this study was to present data on 
prevalence, clinical characteristics and prenatal 
diagnosis of oesophageal atresia in Europe using a 
large European database of congenital anomalies 
(EUROCAT).
METHODS
The study is based on routinely collected data from 
23 European registries of congenital anomalies 
(EUROCAT). The registries are population-based 
and cover geographically well-defi ned populations 
including all births from mothers residing in the 
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registry area. For further details on population coverage and reg-
istration methods see http://www.eurocat-network.eu.26 The 
registries are all based on multiple sources of information includ-
ing hospital records, birth and death certifi cates and postmor-
tem examinations, and include information about live births, 
fetal deaths with gestational age ≥20 weeks and termination of 
pregnancy after prenatal diagnosis of fetal anomaly (termination 
of pregnancy for fetal anomaly (TOPFA). All structural anoma-
lies, syndromes and chromosomal anomalies are included in the 
database except minor and poorly specifi ed anomalies as defi ned 
by the EUROCAT exclusion list.27 Only cases with diagnosis of 
oesophageal atresia confi rmed postnatally are included in the 
database, except for a few prenatally diagnosed TOPFA cases 
where postmortem examination was not performed.
All cases with oesophageal atresia coded with relevant 
WHO International Classifi cation of Diseases 9 (ICD9) code 
(75030, 75031) or ICD10 code (Q 39.0 and Q 39.1) and delivered 
during 1987–2006 were included in this study. Not all regis-
tries covered all years.
Data items included in the analysis are: birth outcome, year 
of birth, infant sex, gestational age, time of diagnosis (pre or 
postnatally), death within the fi rst week after birth and infor-
mation on associated anomalies, syndromes or associations.
The EUROCAT fl owchart for multiple anomalies was used 
to fi nd the potential multiple anomaly cases.27
These cases were manually reviewed by a paediatrician 
(EG) and a geneticist (EC) and classifi ed as isolated oesopha-
geal atresia, multiple congenital anomalies (two or more major 
anomalies in different organ systems), chromosomal or non-
chromosomal syndrome or association. Throughout this paper 
isolated oesophageal atresia is defi ned as oesophageal atresia 
gross type A–D without associated anomalies.
The total number of births covered by the 23 registries over 
the period of study years was 5 019 804.
Continuous variables were presented as means and SDs and 
categorical variables as numbers and percentages. We used the 
Student t test to test for differences between independent con-
tinuous variables and the χ2 test to test for differences between 
categorical variables. Due to a non-Gaussian distribution of 
gestational age, the median and IQR and a Mann–Whitney 
test were used to compare groups. A p value <0.05 was con-
sidered statistically signifi cant. STATA V.9.2 was used for the 
statistical analysis.
RESULTS
During the study period 1222 cases of oesophageal atresia from 
the 23 registries were recorded giving a total prevalence of 2.43 
per 10 000 births (95% CI 2.30 to 2.57). Large regional differ-
ences were found in both the total prevalence of all cases of 
oesophageal atresia and in the prevalence of isolated oesopha-
geal atresia (table 1 and fi gure 1).
The overall prevalence of oesophageal atresia in the two 10 
year periods (1987–1996 and 1997–2006) was 2.37 and 2.46 per 
10 000 births. This difference between the two decades did 
not reach statistical signifi cance. For prevalence of oesopha-
geal atresia, isolated oesophageal atresia and prenatal diagno-
sis over time see fi gure 1.
A total of 1084 of 1222 cases (88.7%) were live births, 43 
(3.5%) were fetal deaths and 95 (7.8%) cases resulted in termina-
tion of pregnancy. Among the 1222 cases there were 700 males 
(57.3%) and 517 females (42.3%) giving a male:female ratio of 
1:0.74. In four cases the sex was indeterminable and in one case 
sex was not recorded in the registry. A breakdown of infant sex 
and birth type for all subgroups is provided in table 2.
Table 1 Number of cases, prevalence, number of cases with prenatal diagnosis and prenatal detection rate by registry
Registry Country Years included Total births Total cases
Total prevalence* 
(95% CI)
Cases with prenatal 
diagnosis
% Prenatal diagnosis 
(95% CI)
Mainz Germany 1990–2006 59403 27 4.55 (3.13 to 6.61) 14 51.9 (33.9 to 69.4)
Odense Denmark 1987–2006 110788 47 4.24 (3.1 to 5.64) 6 12.8 (6.1 to 25.2)
Emilia Romagna Italy 1987–2006 540233 186 3.44 (2.97 to 3.96) 50 26.9 (21.0 to 33.9)
Strasbourg France 1987–2004 231322 75 3.24 (2.59 to 4.06) 27 36.0 (26.1 to 47.3)
Northern Region UK 2000–2006 214037 65 3.04 (2.38 to 3.87) 35 53.8 (41.8 to 65.4)
Vaud Switzerland 1989–2006 134746 39 2.89 (2.12 to 3.96) 12 30.8 (18.6 to 46.5)
Styria Austria 1987–2005 228231 61 2.67 (2.08-3.43)
Wales UK 1998–2006 288877 76 2.63 (2.10-3.29) 32 42.1 (31.6 to 53.4)
The Netherlands Netherlands 1987–2006 375050 94 2.51 (2.10 to 3.10) 25 26.6 (18.7 to 36.4)
Isle de Reunion France 2002–2006 73023 17 2.33 (1.46 to 3.73) 10 58.8 (35.7 to 78.5)
Wessex UK 1994–2006 341119 79 2.32 (1.86 to 2.89) 37 46.8 (36.2 to 57.8)
Saxony Anhalt Germany 2000–2006 123241 28 2.27 (1.58 to 3.28)
Antwerp Belgium 1993–2006 222265 50 2.25 (1.71 to 2.97)
Ukraine Ukraine 2005–2006 54193 11 2.03 (1.14 to 3.63) 6 54.5 (27.7 to 78.9)
Trent UK 1998–2006 549515 108 1.97 (1.63 to 2.37)
Dublin Ireland 1987–2006 412564 81 1.96 (1.58 to 2.44)
Malta Malta 1991–2006 71754 14 1.95 (1.17 to 3.27) 1 7.1 (1.7 to 31.9)
Tuscany Italy 1988–2006 430462 80 1.86 (1.49 to 2.31) 12 15.0 (8.8 to 24.4)
Barcelona Spain 1993–2006 182683 30 1.64 (1.15 to 2.34) 15 50.0 (33.1 to 66.9)
Thames Valley UK 1991–2006 140203 23 1.64 (1.10 to 2.46) 7 30.4 (15.6 to 51.1)
Cork and Kerry Ireland 1997–2003 55630 8 1.44 (0.74 to 2.83) 3 37.5 (13.7 to 70.1)
South East Ireland Ireland 1997–2005 54837 7 1.28 (0.63 to 2.63)
Zagreb Croatia 1987–2006 125628 16 1.27 (0.79 to 2.07) 1 6.3 (1.5 to 28.7)
Total  1987–2006 5019804 1222 2.43 (2.30 to 2.57) 293 of 887 33.0 (30.0 to 36.2)
The prevalence of oesophageal atresia in the 23 regions ranged from 1.27 per 10 000 births in Zagreb and 1.28 per 10 000 births in South East Ireland to 4.24 per 10 000 
births in Odense and 4.55 per 10 000 births in Mainz.
*Rate per 10 000.
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Associated anomalies
The 1222 cases were classifi ed in three groups: 546 (44.7%) 
had an isolated oesophageal atresia, 386 (31.6%) had mul-
tiple anomalies, 290 (23.7%) had an association or syndrome 
(table 2). Syndromic cases or those with associated anomalies 
were subdivided in the following six groups: 117 (9.6%) had 
VACTERL association, 12 cases (1.0%) CHARGE syndrome, 
56 cases (4.6%) had another non-chromosomal syndrome, 23 
cases (1.9%) Down’s syndrome, 72 cases (5.9%) Edward’s syn-
drome and 10 cases (0.8%) another chromosomal syndrome.
The most common associated anomalies among the 1222 
cases were other gastrointestinal anomalies, congenital heart 
Figure 1 Total prevalence, prevalence of isolated oesophageal atresia (OA) and prevalence of prenatal diagnosis per year.
Table 2 Classifi cation of oesophageal atresia cases, infant sex distribution and birth outcome
Specifi ed Number Percentage Sex Number Percentage Birth type Number Percentage
Isolated oesophageal atresia 546 44.7 Male 310 56.8 LB 535 98.0
Female 234 42.9 SB 8 1.5
I/NK 2 0.4 TOPFA 3 0.5
VACTERL association 117 9.6 Male 68 58.1 LB 94 80.3
Female 48 41.0 SB 3 2.6
I/NK 1 0.9 TOPFA 20 17.1
CHARGE syndrome 12 1.0 Male 6 50.0 LB 12 100.0
Female 6 50.0 SB 0 0.0
TOPFA 0 0.0
Other non-chromosomal syndrome 56 4.6 Male 34 60.7 LB 49 87.5
Female 22 39.3 SB 2 3.6
TOPFA 5 8.9
Down’s syndrome 23 1.9 Male 14 60.9 LB 17 73.9
Female 9 39.1 SB 1 4.3
TOPFA 5 21.7
Edward’s syndrome 72 5.9 Male 31 43.1 LB 29 40.3
Female 41 56.9 SB 15 20.8
TOPFA 28 38.9
Other chromosomal syndrome 10 0.8 Male 6 60.0 LB 7 70.0
Female 4 40.0 SB 0 0.0
TOPFA 3 30.0
Multiple malformed 386 31.6 Male 231 59.8 LB 341 88.3
Female 153 39.6 SB 14 3.6
I/NK 2 0.5 TOPFA 31 8.0
Total 1222 100.0 Male 700 57.3 LB 1084 88.7
Female 517 42.3 SB 43 3.5
I/NK 5 0.4 TOPFA 95 7.8
I/NK, indeterminate/not known; LB, live birth; SB, stillbirth; TOPFA, termination of pregnancy for fetal anomaly.
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Gestational age
Gestational age at birth was less than 37 weeks for 401 of the 
1042 (38.5%) live born infants with data on gestational age. 
For live born infants with isolated oesophageal atresia 32.3% 
were born preterm and for live born infants with associated 
anomalies 40.6% were born preterm. For live born infants 
diagnosed postnatally with isolated oesophageal atresia 32.4% 
were born preterm.
Termination of pregnancy
Of the 351 prenatally diagnosed cases termination of preg-
nancy was performed in 95 cases (27.1%). Median gestational 
age at prenatal diagnosis was 20 weeks (18–23 weeks) and 34 
cases were diagnosed before gestational age 20 weeks. There 
were 20 TOPFA cases with VACTERL, 28 with Edward’s syn-
drome, 31 were multiple malformed and only three TOPFA 
cases had isolated oesophageal atresia (table 2).
Survival
Data on 1-week survival was available from 19 registries (four 
registries were excluded as data on 1-week survival was miss-
ing for >10% of cases). One-week survival for all live births was 
86.9% ranging from 92.9% for cases with isolated oesophageal 
atresia to 11.5% for cases with Edward syndrome (table 3). In 
11 registry areas 1-week survival for isolated oesophageal atre-
sia was 100% and lowest regional 1-week survival was 87.5% 
with isolated oesophageal atresia. One-week survival rate in 
live born cases with isolated oesophageal atresia, gestational 
age ≥38 weeks and data on survival was 99.2%.
defects, and limb and urinary tract anomalies. Associated con-
genital heart defects was diagnosed in 359 of cases (29.4%), 
urinary tract anomalies in 200 cases (16.4%), other gastroin-
testinal anomalies in 190 cases (15.5%) and limb anomalies in 
160 cases (13.1%). The most common congenital heart defects 
associated with oesophageal atresia were tetralogy of fallot, 
atrial septal defect, ventricular septal defect and transposition 
of the great arteries.
Tracheo-oesophageal fi stula
Based on the WHO ICD9 and ICD10 codes provided by the 
registries, 581 of the 925 live born cases (72.2%) had an asso-
ciated tracheo-oesophageal fi stula. The frequency of tracheo-
oesophageal fi stula in cases with isolated oesophageal atresia 
was 69.0% and 75.4% for cases with associated anomalies 
(table 3).
Time of diagnosis
Prenatal detection rates showed large regional differences with 
rates between 50% and 65% in Barcelona, Mainz, Ukraine, 
Thames Valley, Isle de Reunion and Northern Region, UK but 
<10% in Zagreb and Malta. Over the two decades 1987–1996 
and 1997–2006 there was a statistically signifi cant increase 
in prenatal detection rates (26.0% and 36.5% respectively, 
χ2=9.65, p<0.01).
For 96.5% (n=693) of the live born cases with a postnatal 
diagnosis, the time of diagnosis was known: 83.4% of these 
cases were detected at birth, 15.4% within the fi rst week of 
life and 1.2% of cases after the fi rst week of life.
Table 3 One-week survival and frequency of trachea-oesophageal fi stula (TF) for all live born cases with oesophageal atresia given per subgroup
Specifi ed
Number of live 
births
Survival beyond 
1 week Number Percentage TF* Number* Percentage*
Isolated oesophagealatresia 438 Yes 407 92.9 Yes 281 69.0
No 15 3.4 No 126 31.0
NK 16 3.7
VACTERL association 89 Yes 77 86.5 Yes 65 84.4
No 11 12.4 No 12 15.6
NK 1 1.1
CHARGE syndrome 7 Yes 5 71.4 Yes 4 80.0
No 2 28.6 No 1 20.0
NK 0
Other non-chromosomal syndrome 45 Yes 36 80.0 Yes 32 88.9
No 9 20.0 No 4 11.1
NK 0
Down’s syndrome 15 Yes 12 80.0 Yes 4 33.3
No 3 20.0 No 8 67.7
NK 0
Edward’s syndrome 26 Yes 3 11.5 Yes 2 67.7
No 22 84.6 No 1 33.3
NK 1 3.8
Other chromosomal syndrome 6 Yes 5 83.3 Yes 4 80.0
No 1 16.7 No 1 20.0
NK 0
Multiple malformed 299 Yes 259 86.6 Yes 189 73.0
No 34 11.4 No 70 27.0
NK 6 2.0
Total 925 Yes 804 86.9 Yes 581 72.2
No 97 10.5 No 224 27.8
NK 24 2.6
*Data on TF only on live born cases surviving more than 1 week.
NK, not known.
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DISCUSSION
This population-based case series describes in a standardised 
way a large number of cases with oesophageal atresia showing 
a total prevalence of 2.43 cases per 10 000 births. No differ-
ences in the prevalence over time were observed in this study, 
in accord with the EUROCAT statistical monitoring report for 
2007 that did not show any pan-European increase in the inci-
dence for oesophageal atresia for the years 1998–2007.28
Large variations in prevalence were found within this 
European population suggesting that there is a real difference 
in prevalence of oesophageal atresia across Europe as the reg-
istries all followed a standardised methodology. It is known 
for other congenital anomalies such as facial clefts, neural tube 
defects and omphalocele that there are regional European dif-
ferences in prevalence.29–31 However, there may be some under 
ascertainment of oesophageal atresia cases in the registries 
with the lowest prevalence. There was no obvious pattern 
in the differences of prevalence in terms of a north–south or 
east–west gradient. We found large regional differences in both 
the prevalence of all cases and in cases with isolated oesopha-
geal atresia. In registries with prevalence below 2 per 10 000 
births the fraction of non-isolated cases was lower than that in 
the other registries. This fi nding might be due to under diag-
nosis of oesophageal atresia in cases with multiple anomalies 
and syndromic cases dying before the oesophageal atresia is 
recognised.
Depaepe et al1 analysed 442 cases of oesophageal atresia 
including cases with isolated tracheo-oesophageal fi stula born 
during 1980–1988 and found an overall prevalence of 2.86 
per 10 000 births, a signifi cantly higher prevalence (p<0.01) 
compared with the total prevalence in the present study. This 
difference may be explained by their inclusion of cases with 
isolated tracheo-oesophageal fi stula.
We found a high proportion of associated anomalies with 
only 44.7% of all cases with an isolated oesophageal atresia. 
This high proportion of associated anomalies has been reported 
by others.1 3–6 13 14 16–22 Although most other major congenital 
anomalies are reported with a percentage of isolated cases up 
to 90%, cases with hydrocephalus and omphalocele also make 
up this high proportion of associated anomalies as for oesoph-
ageal atresia.29 30 32 33 It is important to evaluate the fetus for 
associated anomalies as these can be of prognostic and thera-
peutic importance for the baby at birth or later in infancy.
In the present report a tracheo-oesophageal fi stula was found 
in 72.2 % of cases, 69.0% of cases with isolated oesophageal 
atresia and 75.4% of cases with non-isolated oesophageal atre-
sia. Previous literature, mainly based on surgical data indicates 
that up to 90% of cases have a fi stula.6 10 14 17 34–36
In the present study the knowledge of a trachea-oesophageal 
fi stula is based on the WHO ICD9 and 10 code given by the 
local registry. All cases with tracheo-oesophageal fi stula may 
not be reported to us using the correct code. However, we used 
data from all infants and fetuses and not only those that reach 
the surgeon. In our data we have a slightly lower percentage 
for tracheo-oesophageal fi stula among fetal deaths (68.5%) 
compared with 71.5% of live births. Our data suggest that the 
percentage of oesophageal atresia cases with tracheo-oesoph-
ageal fi stula in the total population of cases with oesophageal 
atresia is lower than among those surviving until surgery.
During the 20 year study period the prenatal detection rate 
increased signifi cantly. There was no difference in mortality 
in the group of cases diagnosed with isolated oesophageal 
atresia pre or postnatally over time as mortality was low in 
both groups. In 2004 one or more ultrasound investigations 
were offered to all pregnant women in all registries included 
in this study except for Malta and The Netherlands. All coun-
tries offering ultrasound screening had a scan performed in the 
second trimester of pregnancy.37
We found that one third of live born infants with isolated 
oesophageal atresia were born preterm (gestational age <37 
weeks) and if associated anomalies were present, the propor-
tion was even higher. The reported rate of preterm births in the 
European population ranged from 5.5% to 7.2%.38 39 The fi nd-
ing of such a high proportion of premature births is probably 
related to the hydramnion associated with oesophageal atresia.
In 7.8% of all cases termination of pregnancy was performed 
with the majority of terminations performed for cases with 
associated anomalies. The terminations may have been due to 
the severity of the associated anomalies. Some of these asso-
ciated anomalies such as Edward’s syndrome, CHARGE syn-
drome have a high mortality in the neonatal period. Therefore, 
comparison of mortality for oesophageal atresia by region may 
be problematic as the number of termination of pregnancies 
and the number of live births with associated anomalies may 
differ between regions and countries depending on laws and 
policies and prenatal screening programmes.37
More than 90% of live births with isolated oesophageal 
atresia were alive at 1 week of age. The survival rate for live 
births with associated anomalies was lower. Long-term mor-
tality is reported to be low,40 but morbidity in childhood is 
high due to poor growth early in life, recurrent airway infec-
tions, chronic lung disease, as well as oesophageal strictures, 
gastro-oesophageal refl ux, swallowing diffi culties, and mus-
culoskeletal problems due to either associated anomalies or as 
a complication to thoracotomy.6 41–45
Primary prevention of oesophageal atresia is currently not 
possible as the aetiology is still unknown. A better understand-
ing of the epidemiology and genetics and a higher prenatal 
detection rate might contribute to better outcomes as parents 
and care providers would be better prepared to manage a child 
with this anomaly.
CONCLUSIONS
In this study the overall European prevalence of oesophageal 
atresia was 2.43 per 10 000 births and did not change over 
time. Large regional differences in the prevalence of oesopha-
geal atresia and in the prenatal detection rate of oesophageal 
atresia were observed. Prenatal detection rates increased over 
time. For newborns with isolated oesophageal atresia 1-week 
survival was excellent although a considerable proportion of 
these infants were born preterm. Oesophageal atresia is often 
associated with other major anomalies, congenital heart defects 
being the most frequent (30% of cases of oesophageal atresia).
The frequency of termination of pregnancy is rather low 
taking the large number of associated anomalies into consid-
eration. The study enhances the epidemiological information 
available for oesophageal atresia.
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